MedTrace Logo

Symptomatic Relief of Acute Dyspeptic Pain in Emergency Department With Pantoprazole

NCT01281501 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 87

Last updated 2013-09-18

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to evaluate the immediate synergistic effect on the relief of severe acid-related dyspeptic pain by adding intravenous pantoprazole to the combination of oral antacid and antispasmodic agent (the conventional treatment).

Conditions

  • Dyspepsia
  • Emergency
  • Pain

Interventions

DRUG

Normal saline

10 ml of 0.9% sodium chloride solution

DRUG

Pantoprazole

80 mg of intravenous pantoprazole

DRUG

Oral antacid

30 ml of oral antacid (1.32 grams of aluminum hydroxide, 0.72 grams of magnesium hydroxide)

DRUG

Hyoscine butylbromide

20 mg of intravenous hyoscine butylbromide

Sponsors & Collaborators

  • Chulalongkorn University

    lead OTHER

Principal Investigators

  • Khrongwong Musikatavorn, MD · Department of Medicine, Faculty of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
15 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-01-31
Primary Completion
2011-10-31
Completion
2011-10-31

Countries

  • Thailand

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01281501 on ClinicalTrials.gov